• Ready to Connect During the 2019 Spring Hospital Pharmacy Conference

    Justin Rolling, Krista Scanlon and Rhodie Smith are attending the Health Connect Partners (HCP) 2019 Spring Hospital Pharmacy Conference, May 6 – 8 in Miami. During the event, America’s most prestigious hospitals and health systems will come together to gain industry-leading insight and education and network through the two Reverse EXPO sessions.   Be sure to connect… Read more »

  • Achieve more with advanced analytics

    Did you know? Mixed-use inventory virtualization and replenishment platforms through RxStrategies are secure, user-friendly, highly customizable and work with all wholesalers and EHRs. In fact, RxStrategies’ integration of the Medi-Span drug database minimizes the need for manual NDC and multiplier mapping, while system-logic seamlessly complies with state-level MCO reporting requirements.   Real-time drug cost analytics… Read more »

  • Simplify 340B with Dashboard Analytics

    Our powerful analytics platform provides users with robust and insightful visibility into their 340B program. With an intuitive, cloud-based platform, an advanced reporting machine, and reliable analytics, RxStrategies’ Dashboard Analytics solution simplifies your entire 340B program. Real-time accumulator views, WAC-spend analyses, robust drill-down capabilities, and custom report creations provide our users access to the exact… Read more »

  • The Future of Policy at NACHC 2019

      March 27 – 30, RxStrategies representatives Rhodie Smith and Justin Rolling will attend the 2019 Policy and Issues Forum hosted by the National Association of Community Health Centers (NACHC). As one of the largest conferences on health policy, people from all corners of the administration and operations of health care will attend. The priorities… Read more »

  • 340B Program Compliance. Achieve More With Intuitive Solutions.

    It was great to connect with industry leaders during the 15th Annual 340B Coalition Winter Conference! As a pharmacist, clinic director, or C-suite executive, one of your top priorities is to provide safe and cost-effective care and ensure regulatory compliance.   RxStrategies understands the complexities of the 340B program and recognizes the importance of open communication… Read more »

  • Clinical Insights: January 31, 2019

    Welcome to RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Tosymra™ (sumatriptan) – New Drug Approval – January 28, 2019 – Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC announced the approval of… Read more »

  • Contract Pharmacy Solutions at 340B Winter Conference

    RxStrategies emphasizes a conservative approach to 340B contract pharmacy administration to maintain program compliance. Our simple, all-inclusive fee ensures more of the 340B savings remain with the Covered Entity. In addition, our audit-proven eligibility matching algorithm drives matches to qualify each individual transaction. Our Split Billing platform simplifies the process of mixed-use inventory virtualization and… Read more »

  • Clinical Insights – December 27, 2018

    Welcome to the December 27, 2018 edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. New Drug Approval  Ultomiris™ (ravulizumab)– New Drug Approval – December 21, 2018 – The U.S. Food and Drug Administration approved Ultomiris™ (ravulizumab) injection for the treatment of adult patients with paroxysmal… Read more »

  • Stay Abreast of 340B Happenings

    It’s that time of year again! The 340B Coalition Winter Conference is upon us. Taking place January 30 – February 1 in San Diego, CA, this prestigious conference offers health care providers, contract pharmacies, pharmaceutical manufacturers, 340B-oriented businesses and government agencies opportunities to network with other 340B leaders and stay informed of the latest industry… Read more »

  • 340B Insider – December 2018

    Welcome to the December edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. Visit our website to read more.   340B INDUSTRY NEWS Read below for recent news from 340B Health. THE U.S. HOUSE PASSES BILL TO KEEP DRUG COMPANIES FROM OVERCHARGING MEDICAID The bipartisan bill, from… Read more »